This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Treatments:Cancer

From Proteopedia

Revision as of 09:54, 13 February 2019 by Michal Harel (Talk | contribs)
Jump to: navigation, search
Anti-CD20 Monoclonal Antibody
Anti-melanoma Monoclonal Antibody
B-Raf Kinase Inhibitor
  • Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032)
Chemotherapy
Dihydrofolate Reductase Inhibitor
  • Alimta - Generic: Pemetrexed
  • Folotyn - Generic: Pralatrexate
  • Methotrexate
  • Raltitrexed
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Modulator
  • Evista - Generic: Raloxifene
  • Fareston - Generic: Toremifene
  • Nolvadex - Generic: Tamoxifen
Multiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor

Proteopedia Page Contributors and Editors (what is this?)

David Canner, Alexander Berchansky, Michal Harel, Karsten Theis

Retrieved from "http://52.214.119.220/wiki/index.php/Treatments:Cancer"
Personal tools